Neonatal onset in fatty acid oxidation disorders: how can we minimize morbidity and mortality?
Riudor
E
E
Laboratori de Metabolopaties, Hospital Materno-Infantil Vall d'Hebron, Barcelona, Spain.
D005227:Fatty Acids / Q000378:metabolism*; D005820:Genetic Testing; D006801:Humans; D007231:Infant, Newborn; D008052:Lipid Metabolism, Inborn Errors / Q000453:epidemiology* / Q000401:mortality* / Q000517:prevention & control; D009017:Morbidity; D015997:Neonatal Screening
D005227:Fatty Acids